Acoramidis is a pharmaceutical compound developed as a near-complete transthyretin stabilizer, used in the manufacture of medications for cardiomyopathy. It is designed to mimic the protective properties of a naturally occurring mutation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Acoramidis?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Acoramidis hydrochloride
pharmaceutical raw material
Olmesartan
pharmaceutical raw material
Olmesartan medoxomil
pharmaceutical raw material
Telmisartan
pharmaceutical raw material
Telmisartan tert-butyl ester
pharmaceutical raw material
The international HS code for Acoramidis (CAS 1446711-81-4) is 2933.19.
2933.19
2933 19 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid
WBFUHHBPNXWNCC-UHFFFAOYSA-N
CC1=C(C(=NN1)C)CCCOC2=C(C=CC(=C2)C(=O)O)F
Sourcing Acoramidis?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.